OrthogenRx
Medical DevicesPennsylvania, United States11-50 Employees
OrthogenRx, Inc., now part of Avanos Medical, is a medical device company focused on developing and commercializing treatments for musculoskeletal conditions, including osteoarthritis. Headquartered in Doylestown, Pennsylvania, it positions itself as an early-stage private enterprise, pursuing viscosupplementation therapies for knee OA. Its lead products include GenVisc 850, a five-injection hyaluronic acid formulation derived from non-avian source material, and TriVisc, a three-injection regimen. TriVisc has been launched in the United States to treat osteoarthritic knee pain in patients who have not achieved adequate relief from basic analgesics or exercise and physical therapy. In December 2021, OrthogenRx was acquired by Avanos Medical, reflecting a change in ownership within the medical device ecosystem while continuing to focus on its viscosupplementation therapies. The company maintains a relatively small team addressing a specialized segment within medical equipment manufacturing.
1-888-653-2347 
support@leadiq.com 
